Income statement - Novozymes A/S


Audited by PwC
2009 2008
Note     DKK million  DKK million  
1 Revenue 4,682  4,719 
2 Cost of goods sold   2,565  2,634   
  Gross profit 2,117  2,085 
   
2 Sales and distribution costs 620  537 
2 Research and development costs 926  845 
2, 3 Administrative costs 441  372 
Other operating income, net 906  1,049   
Operating profit 1,036  1,380 
7 Income before tax on investments in subsidiaries 661  22 
4 Financial income 171  198 
4 Financial costs   302  264   
Profit before tax 1,566  1,336 
Corporation tax   413  336   
Net profit 1,153  1,000 
Proposed appropriation of net profit
Dividend to shareholders 358  325 
Revaluation reserve according to the equity method (200) (334)
Retained earnings   995  1,009   
1,153  1,000 
Proposed dividend per share 5.75  5.25 
My Report